$101 Thousand is the total value of PERKINS CAPITAL MANAGEMENT INC's 98 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| USIO | Buy | Usio Inc | $1,759 | +234.4% | 1,005,193 | +255.3% | 1.74% | +280.8% |
| AXGN | Buy | Axogen Inc | $1,507 | -44.8% | 301,340 | +0.8% | 1.49% | -37.2% |
| Buy | MDxHealth SAsponsored adr | $1,132 | -17.7% | 404,225 | +0.2% | 1.12% | -6.3% | |
| EMKR | Buy | Emcore Corp | $1,106 | +77.8% | 2,326,000 | +181.6% | 1.10% | +102.2% |
| New | Real Good Food Company I | $496 | – | 148,000 | +100.0% | 0.49% | – | |
| USB | Buy | US Bancorp DEL | $495 | +2.1% | 14,984 | +2.0% | 0.49% | +16.1% |
| AKTS | Buy | Akoustis Technologies Inc | $450 | -73.8% | 597,500 | +10.8% | 0.45% | -70.2% |
| New | Fortress Biotech Inc | $408 | – | 1,406,513 | +100.0% | 0.40% | – | |
| New | Aspira Womens Health Inc | $268 | – | 50,000 | +100.0% | 0.27% | – | |
| New | Creative Realities Inc | $155 | – | 100,050 | +100.0% | 0.15% | – | |
| NMTC | New | NeuroOne Med Technologies CO | $134 | – | 150,000 | +100.0% | 0.13% | – |
| CDXS | New | Codexis Inc | $43 | – | 22,600 | +100.0% | 0.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-02
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEOGENOMICS INC | 41 | Q3 2023 | 7.8% |
| LILY ELI & CO | 41 | Q3 2023 | 6.9% |
| PFIZER INC | 41 | Q3 2023 | 2.9% |
| ATTUNITY LTD | 41 | Q3 2023 | 3.6% |
| EXPEDITORS INTL WASH INC | 41 | Q3 2023 | 2.3% |
| CVS HEALTH CORP | 41 | Q3 2023 | 1.6% |
| DONALDSON INC | 41 | Q3 2023 | 1.3% |
| VERIZON COMMUNICATIONS INC | 41 | Q3 2023 | 1.0% |
| US BANCORP DEL | 41 | Q3 2023 | 0.8% |
| BAXTER INTL INC | 40 | Q3 2023 | 14.1% |
View PERKINS CAPITAL MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| BIOLASE, INC | May 15, 2023 | 689,196 | 2.1% |
| FlexShopper, Inc. | February 09, 2023 | 1,281,460 | 5.9% |
| Avinger Inc | February 14, 2020 | 891,761 | 5.2% |
| Black Ridge Oil & Gas, Inc. | February 15, 2019 | 30,021,032 | 6.3% |
| CANCER GENETICS, INC | February 15, 2019 | 1,135,250 | 4.0% |
| TearLab Corp | February 15, 2019 | 1,666,294 | 13.1% |
| Xtant Medical Holdings, Inc. | February 15, 2019 | 684,408 | 3.6% |
| TearLab Corp | January 26, 2018 | 4,300,655 | 40.1% |
| BIO KEY INTERNATIONAL INC | February 09, 2017 | 274,900 | 4.4% |
| EnteroMedics Inc | February 09, 2017 | 1,455 | 0.0% |
View PERKINS CAPITAL MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-09 |
| 13F-HR | 2024-01-22 |
| 13F-HR | 2023-11-02 |
| 13F-HR | 2023-07-21 |
| SC 13G/A | 2023-05-15 |
| 13F-HR | 2023-05-09 |
| SC 13G/A | 2023-02-09 |
| SC 13G | 2023-02-09 |
| 13F-HR | 2023-01-26 |
| 13F-HR | 2022-10-24 |
View PERKINS CAPITAL MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.